U.S. Pharmaceutical Sales - Q2 2013

The following is a list of the top 100 prescribed medicines by U.S. National Sales in Q2 2013. Figures include sales through both retail and hospital channels, listed by drug name and sales value in U.S. dollars.

Last updated: February 2014 (updated quarterly).

Top 100 Drugs for Q2 2013 by Sales

Rank Drug Sales ($000)
1 Abilify
Otsuka Pharmaceutical Co., Ltd
4.70% Stats
2 Nexium
AstraZeneca Pharmaceuticals, LP
-0.34% Stats
3 (3) Humira
AbbVie, Inc.
10.22% Stats
4 (1) Cymbalta
Eli Lilly and Company
3.24% Stats
5 (1) Crestor
AstraZeneca Pharmaceuticals, LP
-0.37% Stats
6 (1) Advair Diskus
GlaxoSmithKline
-2.80% Stats
7 Enbrel
Amgen Inc.
6.76% Stats
8 Remicade
Centocor Ortho Biotech, Inc
2.76% Stats
9 Copaxone
Teva Pharmaceuticals
0.79% Stats
10 Neulasta
Amgen Inc.
0.21% Stats
11 Rituxan
Genentech, Inc (member of Roche group)
3.96% Stats
12 Spiriva
Boehringer Ingelheim Pharmaceuticals, Inc
-0.42% Stats
13 Atripla
Gilead Sciences, Inc.
-1.24% Stats
14 Januvia
Merck & Co., Inc.
-1.23% Stats
15 (2) Lantus Solostar
Sanofi (formerly Sanofi Aventis)
7.11% Stats
16 Avastin
Genentech, Inc (member of Roche group)
4.22% Stats
17 (2) OxyContin
-4.71% Stats
18 Lantus
Sanofi (formerly Sanofi Aventis)
1.18% Stats
19 Lyrica
Pfizer Inc
3.53% Stats
20 (1) Truvada
Gilead Sciences, Inc.
2.78% Stats
21 (2) Epogen
Amgen Inc.
9.40% Stats
22 Celebrex
Pfizer Inc
2.85% Stats
23 (3) Diovan
Novartis Corporation
-0.99% Stats
24 (2) Gleevec
Novartis Corporation
7.85% Stats
25 Namenda
Forest Pharmaceuticals, Inc
4.67% Stats
26 (2) Herceptin
Genentech, Inc (member of Roche group)
-0.74% Stats
27 (2) Lucentis
Genentech, Inc (member of Roche group)
9.07% Stats
28 (1) Vyvanse
Shire US Inc
-6.66% Stats
29 (2) Zetia
Merck & Co., Inc.
0.89% Stats
30 (4) Symbicort
AstraZeneca Pharmaceuticals, LP
1.89% Stats
31 (7) Lidoderm
Endo Pharmaceuticals
10.71% Stats
32 (3) OneTouch
-0.71% Stats
33 (3) enoxaparin
Generic
0.02% Stats
34 (6) Levemir
Novo Nordisk, Inc.
8.40% Stats
35 (2) methylphenidate
Generic
-7.92% Stats
36 (1) AndroGel
AbbVie, Inc.
-0.84% Stats
37 (9) Suboxone
Reckitt Benckiser Pharmaceuticals Inc.
-18.95% Stats
38 (3) Rebif
-1.96% Stats
39 (4) NovoLog FlexPen
Novo Nordisk, Inc.
2.10% Stats
40 (2) Novolog
Novo Nordisk, Inc.
-0.94% Stats
41 (2) Avonex
Biogen Idec
-9.51% Stats
42 (7) Alimta
Eli Lilly and Company
10.84% Stats
43 (1) Seroquel XR
AstraZeneca Pharmaceuticals, LP
-0.49% Stats
44 (2) Nasonex
Merck & Co., Inc.
2.75% Stats
45 Viagra
Pfizer Inc
-1.37% Stats
46 (43) doxycycline
Generic
46.22% Stats
47 (9) ProAir HFA
Teva Pharmaceuticals
5.28% Stats
48 Humalog
Eli Lilly and Company
-1.26% Stats
49 (2) Niaspan
Abbott Laboratories
-3.62% Stats
50 (2) Lovaza
GlaxoSmithKline
-1.47% Stats
51 (9) Victoza
Novo Nordisk, Inc.
8.23% Stats
52 (15) Gilenya
Novartis Corporation
10.75% Stats
53 (2) amphetamine/dextroamphetamine
Generic
-2.74% Stats
54 (1) Flovent HFA
GlaxoSmithKline
-3.99% Stats
55 (6) Procrit
Janssen Pharmaceuticals, Inc
6.00% Stats
56 (1) Cialis
Eli Lilly and Company
0.24% Stats
57 (2) Isentress
Merck & Co., Inc.
3.58% Stats
58 acetaminophen/hydrocodone
Generic
-0.20% Stats
59 (6) Restasis
Allergan, Inc
4.54% Stats
60 (9) Prezista
Janssen Pharmaceuticals, Inc
9.23% Stats
61 (11) budesonide
Generic
-9.50% Stats
62 (11) fenofibrate
Generic
-9.66% Stats
63 (3) metoprolol
Generic
1.44% Stats
64 (10) Orencia
Bristol-Myers Squibb Company
9.63% Stats
65 (1) Reyataz
Bristol-Myers Squibb Company
-0.17% Stats
66 (4) Janumet
Merck & Co., Inc.
-1.98% Stats
67 (4) Neupogen
Amgen Inc.
-3.07% Stats
68 (13) Stelara
10.65% Stats
69 (1) VESIcare
Astellas Pharma US
1.16% Stats
70 (7) Dexilant
Takeda Pharmaceuticals U.S.A., Inc
5.60% Stats
71 () Xarelto
Ortho-McNeil-Janssen Pharmaceuticals, Inc.
Stats
72 (1) Vytorin
Merck & Co., Inc.
-2.71% Stats
73 (2) Pradaxa
Boehringer Ingelheim Pharmaceuticals, Inc
-3.34% Stats
74 (2) Renvela
Genzyme Corporation
-1.52% Stats
75 (7) Incivek
Vertex Pharmaceuticals
-12.42% Stats
76 (3) Benicar
Daiichi Sankyo
-0.04% Stats
77 (6) Synthroid
Abbott Laboratories
1.94% Stats
78 (15) Xolair
11.87% Stats
79 (5) Evista
Eli Lilly and Company
1.91% Stats
80 Aranesp
Amgen Inc.
-1.61% Stats
81 (1) Humalog KwikPen
-0.84% Stats
82 (8) Lunesta
Sunovion Pharmaceuticals Inc.
5.05% Stats
83 (5) Aciphex
Eisai Corporation
-6.17% Stats
84 () Zytiga
Centocor Ortho Biotech, Inc
Stats
85 (10) Prevnar 13
Wyeth
6.00% Stats
86 (8) Xgeva
Amgen Inc.
3.97% Stats
87 Betaseron
Bayer Healthcare Pharmaceuticals
-3.25% Stats
88 (15) modafinil
Generic
-14.37% Stats
89 (8) Xeloda
Roche Pharmaceuticals
6.87% Stats
90 () Invega Sustenna
Janssen Pharmaceuticals, Inc
Stats
91 (5) Sensipar
Amgen Inc.
2.21% Stats
92 (53) Avonex Pen
Biogen Idec
-45.78% Stats
93 (7) Adderall XR
Shire US Inc
-7.28% Stats
94 (4) omeprazole
Generic
4.76% Stats
95 (4) fentanyl
Generic
-4.71% Stats
96 (4) Zyvox
Pfizer Inc
-5.18% Stats
97 (12) Ventolin HFA
GlaxoSmithKline
-11.76% Stats
98 () Sandostatin LAR Depot
Novartis Corporation
Stats
99 (11) atorvastatin
Generic
-10.88% Stats
100 () Afinitor
Novartis Corporation
Stats

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Hide
(web2)